Toby joins Jnana as Vice President, Head of Clinical Operations with over 30 years of experience in all phases of global pharmaceutical and device development across multiple therapeutic areas, including over 25 years in Clinical Operations. Other areas of experience include Preclinical Safety Assessment, Regulatory Affairs and Medical Affairs leading Advisory Boards and providing Medical Scientific Liaison training and development. Before joining Jnana, Toby served as Vice President of Clinical Operations at Sio Gene Therapies. Prior to that, he was Vice President of Clinical Development at Liquidia Technologies. He has been responsible for building Clinical Operations organizations from the ground up – hiring talent, developing infrastructure, and providing management and oversight of clinical trials and programs – for several companies, including Liquidia Technologies, Exact Sciences, Actavis, Warner Chilcott Pharmaceuticals, and Procter and Gamble Pharmaceuticals. His responsibilities have also included the assessment of new technologies and process to drive innovation and efficiency into clinical development programs and lead the vetting and selection of preferred vendors and systems. Toby holds an M.S. degree in Clinical Pharmacology from The Ohio State University School of Medicine, and a B.S. in Biology from Xavier University.